4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001193125-25-331189
Chief R&D Officer acquired 6,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zalevsky Jonathan · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Grant or award : show line 1 in the form | +6,250 | 25,221 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-22 | Grant or award : show line 2 in the form Stock Option | +25,000 | 25,000 | D |
Loading xslF345X05/ownership.xml…